NCT00513474
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +72 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Clinical trial condition
Myeloproliferative Disorders
Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.
500 public trials
86 recruiting studies
Myeloproliferative Disorders trial results
NCT00112593
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00795769
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +202 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis
NCT00572897
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- University of Illinois at Chicago Chicago, Illinois, United States
- Johns Hopkins Baltimore, Maryland, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Icahn School of Medicine at Mount Sinai New York, United States
NCT00509691
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
- Locations
-
- Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
Completed
Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
NCT00248547
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Completed
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
NCT00993694
- Conditions
- Amyloidosis, Anemia, Anemia, Aplastic, +101 more
- Locations
-
- Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT00636909
- Conditions
- ALL, AML, Anemia, +40 more
- Locations
-
Not specified
NCT00755040
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
- Locations
-
- Stanford University Palo Alto, California, United States
- Norwestern Memorial Hospital Chicago, Illinois, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
- M. D. Anderson Cancer Center Houston, Texas, United States
NCT00408681
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +221 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States